Treatment of infantile parotid hemangioma with propranolol / 中华口腔医学杂志
Chinese Journal of Stomatology
;
(12): 292-294, 2010.
Article
in Chinese
| WPRIM
| ID: wpr-245205
ABSTRACT
<p><b>OBJECTIVE</b>To evaluate the short-term results and safety of propranolol for the treatment of infantile parotid hemangioma.</p><p><b>METHODS</b>Oral propranolol was administered to 17 infants with parotid hemangioma at a dose of 1.0-1.5 mg per kilogram of body weight per day. The patients were revisited once a week. The changes of the tumor size, texture and colour were monitored and recorded at a regular interval. The adverse effects after medication were observed and managed accordingly. The short-term results were evaluated using a 4 scales system.</p><p><b>RESULTS</b>Among the 17 patients treated, the follow-up time was 5 to 10 months. The overall response was scale I in 0 patient, scale II in 0 patients, scale III in 5 patients, and scale IV in 12 patients. No serious adverse effects were encountered.</p><p><b>CONCLUSIONS</b>Oral propranolol at a lower dose is a safe and effective method for the treatment of infantile parotid hemangioma. The short-term results were excellent and the side effects minimal.</p>
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Propranolol
/
Parotid Neoplasms
/
Administration, Oral
/
Follow-Up Studies
/
Treatment Outcome
/
Adrenergic beta-Antagonists
/
Therapeutic Uses
/
Drug Therapy
/
Hemangioma
Type of study:
Observational study
/
Prognostic study
Limits:
Female
/
Humans
/
Infant
/
Male
Language:
Chinese
Journal:
Chinese Journal of Stomatology
Year:
2010
Type:
Article
Similar
MEDLINE
...
LILACS
LIS